Abstract
The dispersion model of hepatic elimination is based on the distribution of residence times of blood elements within the liver. The model has two asymptotic solutions corresponding to the “wellstirred” model (complete mixing of blood elements) and the “parallel-tube” model (no variation in residence times of blood elements). The steady-state form of the dispersion model relevant to pharmacokinetic analysis is developed and explored with respect to changes in blood flow, in binding within blood, and in hepatocellular enzyme activity. Literature data are used to evaluate discrepancies among the predictions of the dispersion, well-stirred, and tube models. It is concluded that the dispersion model is consistent-with the data. The limitations of steady-state perfusion experiments to estimate the residence time distribution of blood elements within the liver are considered.
Similar content being viewed by others
References
K. S. Pang and M. Rowland. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and hepatocellular enzymatic activity on hepatic drug clearance.J. Pharmacokin. Biopharm. 5:625–653 (1977).
K. S. Pang and M. Rowland. Hepatic clearance of drugs II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation.J. Pharmacokin. Biopharm. 5:655–680 (1977).
A. B. Ahmad, P. N. Bennett, and M. Rowland. Models of hepatic drug clearance: Discrimination between the “well-stirred” and “parallel-tube” models.J. Pharm. Pharmacol. 35:219–224 (1983).
S. Keiding and E. Chiarantini. Effect of sinusoidal perfusion on galactose elimination in perfused rat liver.J. Pharmacol. Exp. Ther. 205:465–470 (1978).
M. Rowland, D. Leitch, G. Fleming, and B. Smith. Protein binding and hepatic clearance: Discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.J. Pharmacokin. Biopharm. 12:129–147 (1984).
J. J. Gumucio, D. L. Miller, M. D. Krauss, and C. C. Zønolli. Transport of fluorescent compounds into hepatocytes and the resultant zonal labelling of the hepatic acinus in the rat.Gastroenterology 80:639–646 (1981).
L. Bass, P. J. Robinson, and A. J. Bracken. Hepatic elimination of flowing substances: The distributed model.J. Theor. Biol. 72:161–184 (1978).
E. L. Forker and B. Luxon. Hepatic transport kinetics and plasma disappearance curves: Distributed modelling versus conventional approach.Am. J. Physiol. 235:E648-E660 (1978).
D. J. Morgan. Models of hepatic drug elimination: A response.J. Pharm. Sci. 72:1230 (1983).
W. A. Coburn. Albumin binding and hepatic uptake. The importance of model selection-A response.J. Pharm. Sci. 72:1233 (1983).
M. S. Roberts and M. Rowland. A dispersion model of hepatic elimination. 1. Formulation of the model and bolus considerations.J. Pharmacokin. Biopharm. 14:227–260 (1986).
M. S. Roberts and M. Rowland. Hepatic elimination-Dispersion model.J. Pharm. Sci. 74:585–587 (1984).
J. F. Wehner and R. M. Wilhelm. Boundary conditions of flow reactor.Chem. Eng. Sci. 6:89–93 (1956).
O. Levenspiel.Chemical Reaction Engineering, Wiley, New York, 1972, pp. 253–315.
P. Veng-Pederson. Curve fitting and modelling in pharmacokinetics and some practical experience with NONLIN and new program FUNFIT.J. Pharmacokin. Biopharm. 5:513–531 (1977).
R. W. Brauer, G. F. Leong, R. F. McEIroy, Jr., and R. J. Holloway. Circulatory pathways in the rat liver as revealed by32P chromic phosphate colloid uptake in the isolated perfused liver preparation.Am. J. Physiol. 184:593–598 (1956).
T. D. Yih, A. W. Boxmen, and J. M. van Rossum. Influence of liver blood flow on the metabolic clearance of barbiturates in the intact rat and in the isolated liver.Pharm. Weekb. 110:1236–1240 (1975).
T. L. Whitsett, P. G. Dayton, and J. L. McNay. The effect of hepatic blood flow on the hepatic removal rate of oxyphenbutazone in the dog.J. Pharmacol. Exp. Ther. 177:246–255 (1971).
P. V. Dankwerts. Continuous flow systems. Distribution of residence times.Chem. Eng. Sci. 2:1–13 (1953).
D. L. Miller, C. S. Zanolli, and J. J. Gumucio. Quantitative morphology of the sinusoids of the hepatic acinus. Quantimet analysis of rat liver.Gastroenterology 76:965–969 (1979).
A. Koo, I. Y. Liang, and K. K. Cheng. The terminal hepatic microcirculation in the rat.Q. J. Exp. Physiol. 60:261–266 (1975).
J. J. Gumucio. Functional and anatomic heterogeneity in the liver acinus: Impact on transport.Am. J. Physiol. 245:G578-G582 (1983).
E. L. Forker and B. A. Luxon. Analyzing tracer disappearance curves to study hepatic transport kinetics.Am. J. Physiol. 244:G573-G577 (1983).
C. A. Goresky. A linear method for determining liver sinusoidal and extravascular volume.Am. J. Physiol. 204:626–640 (1963).
A. B. Ahmad. Ph.D. Thesis, University of Bath, 1982.
A. Koo and I. Y. S. Liang. β-Adrenoreceptors and rat liver microcirculation.Clin. Exp. Pharmacol. Physiol. 6:403–407 (1979).
T. Yipintsoi and J. B. Bassingwaighte. Circulatory transport of iodoantipyrine and water in the isolated dog heart.Circ. Res. 27:461–477 (1970).
E. A. Ebach and R. R. White. Mixing of fluids flowing through beds of packed solids.Am. Inst. Chem. Eng. J. 4:161–169 (1958).
B. J. Zinolinski, H. Eyring, and C. B. Reese. Diffusion and membrane permeability.J. Phys. Colloid. Chem. 53:1426–1453 (1949).
G. L. Amidon, J. Kou, R. L. Elliott, and E. N. Lightfoot. Analysis of models for determining intestinal wall permeabilities.J. Pharm. Sci. 69:1369–1373 (1980).
E. G. Lovering and D. B. Black. Diffusion layer effects of phenylbutazone through polydimethylsiloxane.J. Pharm. Sci. 63:1399–1402 (1974).
D. G. Thurman and F. C. Kauffman. Factors regulating drug metabolism in intact hepatocytes.Pharmacol. Rev. 31:229–251 (1979).
C. A. Goresky. Kinetic interpretation of hepatic multiple indicator dilution studies.Am. J. Physiol. 245:G1-G12 (1983).
L. Bass and P. J. Robinson. How small is the functional variability of liver sinusoids.J. Theor. Biol. 81:761–769 (1979).
P. D. Richardson and P. G. Withrington. Liver blood flow: II. Effects of drugs and hormones on liver blood flow.Gastroenterology 81:356–375 (1981).
M. Chakravorti and J. Tripod. The action in the perfused liver of acetylcholine, sympathomimetic substances and local anaesthestics.J. Physiol. (Lond.)97:316–329 (1940).
A. B. Ahmad, P. N. Bennett, and M. Rowland. Models of hepatic drug clearance: Discrimination between the “well-stirred” and “parallel-tube” models.J. Pharm. Pharmacol. 35:219–224 (1983).
D. J. Morgan and K. Raymond. Use of unbound drug concentrations in blood to discriminate between two models of hepatic drug elimination.J. Pharm. Sci. 71:600–602 (1982).
E. L. Forker and B. A. Luxon. Albumin binding and hepatic uptake: The importance of model selection.J. Pharm. Sci. 72:1322–1323 (1983).
W. A. Coburn. Albumin does not mediate the removal of taurocholate by the rat liver.J. Pharm. Sci. 71:373 (1982).
E. L. Forker and B. A. Luxon. Albumin helps mediate removal of taurocholate by rat liver.J. Clin. Invest. 67:1517–1522 (1981).
L. R. Schwartz, R. Burr, M. Schwenk, E. Pfaff, and H. Greim. Uptake of taurocholic acid into isolated rat liver cells.Eur. J. Biochem. 55:617–623 (1975).
M. S. Anwer, R. Kroker, and D. Hegner. Effect of albumin on bile acid uptake by isolated rat hepatocytes. Is there a common bile acid carrier?Biochem. Biophys. Res. Commun. 13:63–71 (1976).
T. Iga and C. D. Klassen. Uptake of bile acids by isolated rat hepatocytes.Biochem. Pharmacol. 31:211–216 (1982).
R. K. Ockner, R. A. Weissiger, and J. L. Gollan. Hepatic uptake of albumin bound substances: Albumin receptor concepts.Am. J. Physiol. 245:G13-G18 (1983).
D. B. Jones, D. J. Morgan, G. W. Mihaly, L. K. Webster, and R. A. Smallwood. Discrimination between venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranoiol protein binding.J. Pharmacol. Exp. Ther. 229:522–526 (1984).
S. Keiding and E. Steiness. Flow dependence of propranolol elimination in perfused rat liver.J. Pharmacol. Exp. Ther. 230:474–477 (1984).
A. Rane, G. R. Wilkinson, and D. G. Shand, Prediction of hepatic extraction ratio fromin vitro measurement of intrinsic clearance.J. Pharmacol. Exp. Ther. 200:420–424 (1977).
J. M. Anderson, A. C. Anderson, and L. S. Iben. Hepatic uptake of propranolol.J. Pharmacol. Exp. Ther. 78:172–180 (1978).
A. Koo and I. Y. S. Liang. β2-Adrenoceptors in rat liver vasculature.din. Exp. Pharmacol. Physiol. 6:403–407 (1979).
J. J. Gumucio and D. L. Miller. Function implications of liver cell heterogeneity.Gastroenterology 80:393–403 (1981).
G. R. Wilkinson and D. G. Shand. Commentary. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).
R. E. Billings, R. E. McMahon, J. Ashmore, and S. R. Wagle. The metabolism of drugs in isolated hepatocytes. A comparison ofin vivo drug metabolism and drug metabolism in subcellular liver fractions.Biochem. Pharmacol. 5:516–526 (1977).
N. Tsuri, R. R. Erickson, and J. L. Holtzman. The metabolism of phenytoin in isolated hepatocytes and hepatic microsomes from male rats.J. Pharmacol. Exp. Ther. 222:658–661 (1982).
C. A. Goresky, G. G. Bach, and B. E. Nadeau. On the uptake of materials by the intact liver. The transport and net removal of galactose.J. Clin. Invest. 52:991–1009 (1973).
A. L. Jones, G. T. Hradek, R. H. Renston, K. Y. Weng, G. Karlagancs, and G. Paumgartner. Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative.Am. J. Physiol. 238:G233-G237 (1980).
J. R. Pearson. A note on the “Dankwerts” boundary conditions for continuous flow reaction.Chem. Eng. Sci. 10:281–285 (1959).
A. Rane, G. R. Wilkinson, and D. G. Shand. Prediction of hepatic extraction ratio fromin vitro measurements of intrinsic clearance.J. Pharmacol. Exp. Ther. 200:420–424 (1977).
L. Bass. Saturation kinetics in hepatic drug removal: A statistical approach to functional heterogeneity.Am. J. Physiol. 244:G583-G589 (1983).
L. Bass. Flow dependence of first-order uptake of substances by heterogeneous perfused organs.J. Theor. Biol. 86:365–376 (1980).
Y. Sawada, Y. Sugiyama, Y. Miyamoto, T. Iga, and M. Hanano. Hepatic drug clearance model: Comparison among the distributed, parallel tube and well-stirred models.Chem. Pharm. Bull. 33:319–326 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roberts, M.S., Rowland, M. A dispersion model of hepatic elimination: 2. Steady-state considerations-influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity. Journal of Pharmacokinetics and Biopharmaceutics 14, 261–288 (1986). https://doi.org/10.1007/BF01106707
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01106707